nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapsone—CYP2C9—brain cancer	0.524	1	CbGaD
Dapsone—MPO—Carboplatin—brain cancer	0.146	0.387	CbGbCtD
Dapsone—PTGS2—Etoposide—brain cancer	0.0423	0.112	CbGbCtD
Dapsone—CYP3A4—Temozolomide—brain cancer	0.0407	0.108	CbGbCtD
Dapsone—PTGS1—Etoposide—brain cancer	0.0357	0.0947	CbGbCtD
Dapsone—CYP3A4—Lomustine—brain cancer	0.0346	0.0917	CbGbCtD
Dapsone—CYP2E1—Etoposide—brain cancer	0.0276	0.0732	CbGbCtD
Dapsone—CYP3A5—Etoposide—brain cancer	0.0214	0.0568	CbGbCtD
Dapsone—CYP2C8—Etoposide—brain cancer	0.0206	0.0547	CbGbCtD
Dapsone—CYP3A4—Etoposide—brain cancer	0.00836	0.0222	CbGbCtD
Dapsone—NAT2—pineal body—brain cancer	0.00833	0.27	CbGeAlD
Dapsone—FMO3—Tamoxifen metabolism—CYP2C9—brain cancer	0.00283	0.0487	CbGpPWpGaD
Dapsone—CYP2C18—Xenobiotics—CYP2C9—brain cancer	0.00179	0.0308	CbGpPWpGaD
Dapsone—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.00173	0.0297	CbGpPWpGaD
Dapsone—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00155	0.0267	CbGpPWpGaD
Dapsone—MPO—endothelium—brain cancer	0.00154	0.0499	CbGeAlD
Dapsone—NAT2—endocrine gland—brain cancer	0.00145	0.0471	CbGeAlD
Dapsone—PTGS1—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.00145	0.025	CbGpPWpGaD
Dapsone—MPO—blood vessel—brain cancer	0.00142	0.0461	CbGeAlD
Dapsone—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00141	0.0243	CbGpPWpGaD
Dapsone—CYP2E1—CYP2E1 reactions—CYP2C9—brain cancer	0.00139	0.0239	CbGpPWpGaD
Dapsone—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00138	0.0238	CbGpPWpGaD
Dapsone—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00126	0.0217	CbGpPWpGaD
Dapsone—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.0012	0.0207	CbGpPWpGaD
Dapsone—CYP3A7—Xenobiotics—CYP2C9—brain cancer	0.00119	0.0205	CbGpPWpGaD
Dapsone—PTGS2—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.00115	0.0198	CbGpPWpGaD
Dapsone—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.00107	0.0185	CbGpPWpGaD
Dapsone—PTGS1—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.00101	0.0173	CbGpPWpGaD
Dapsone—Sulfamoxole—CYP2C9—brain cancer	0.00099	0.159	CrCbGaD
Dapsone—Sulfadimethoxine—CYP2C9—brain cancer	0.00099	0.159	CrCbGaD
Dapsone—FMO3—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00099	0.017	CbGpPWpGaD
Dapsone—Sulfapyridine—CYP2C9—brain cancer	0.00091	0.146	CrCbGaD
Dapsone—CYP2E1—Xenobiotics—CYP2C9—brain cancer	0.000862	0.0148	CbGpPWpGaD
Dapsone—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.000861	0.0148	CbGpPWpGaD
Dapsone—FMO3—pituitary gland—brain cancer	0.000852	0.0276	CbGeAlD
Dapsone—PTGS1—ganglion—brain cancer	0.000849	0.0275	CbGeAlD
Dapsone—CYP2E1—Tamoxifen metabolism—CYP2C9—brain cancer	0.000829	0.0143	CbGpPWpGaD
Dapsone—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.000828	0.0142	CbGpPWpGaD
Dapsone—PTGS2—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.000799	0.0137	CbGpPWpGaD
Dapsone—Sulfisoxazole—CYP2C9—brain cancer	0.00075	0.121	CrCbGaD
Dapsone—Sulfamethizole—CYP2C9—brain cancer	0.00075	0.121	CrCbGaD
Dapsone—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000745	0.0128	CbGpPWpGaD
Dapsone—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000744	0.0128	CbGpPWpGaD
Dapsone—CYP2C18—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000734	0.0126	CbGpPWpGaD
Dapsone—PTGS1—endothelium—brain cancer	0.000732	0.0237	CbGeAlD
Dapsone—NAT2—Biological oxidations—CYP2C9—brain cancer	0.000727	0.0125	CbGpPWpGaD
Dapsone—NAT2—Metapathway biotransformation—CYP2C9—brain cancer	0.000717	0.0123	CbGpPWpGaD
Dapsone—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.000717	0.0123	CbGpPWpGaD
Dapsone—PTGS2—endothelium—brain cancer	0.0007	0.0226	CbGeAlD
Dapsone—CYP2C18—endocrine gland—brain cancer	0.000686	0.0222	CbGeAlD
Dapsone—PTGS1—blood vessel—brain cancer	0.000675	0.0218	CbGeAlD
Dapsone—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000665	0.0114	CbGpPWpGaD
Dapsone—FMO3—endocrine gland—brain cancer	0.00066	0.0214	CbGeAlD
Dapsone—CYP3A7—endocrine gland—brain cancer	0.000653	0.0211	CbGeAlD
Dapsone—FMO3—head—brain cancer	0.000652	0.0211	CbGeAlD
Dapsone—PTGS2—blood vessel—brain cancer	0.000645	0.0209	CbGeAlD
Dapsone—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.00064	0.011	CbGpPWpGaD
Dapsone—FMO3—SIDS Susceptibility Pathways—HES5—brain cancer	0.000618	0.0106	CbGpPWpGaD
Dapsone—CYP2C18—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000603	0.0104	CbGpPWpGaD
Dapsone—FMO3—central nervous system—brain cancer	0.000595	0.0193	CbGeAlD
Dapsone—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000591	0.0102	CbGpPWpGaD
Dapsone—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000564	0.0097	CbGpPWpGaD
Dapsone—MPO—pituitary gland—brain cancer	0.000562	0.0182	CbGeAlD
Dapsone—PTGS1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000554	0.00954	CbGpPWpGaD
Dapsone—CYP2C18—FOXA1 transcription factor network—SHH—brain cancer	0.000551	0.00947	CbGpPWpGaD
Dapsone—Sulfadiazine—CYP2C9—brain cancer	0.000544	0.0874	CrCbGaD
Dapsone—FMO3—Biological oxidations—CYP2C9—brain cancer	0.000526	0.00905	CbGpPWpGaD
Dapsone—FMO3—Metapathway biotransformation—CYP2C9—brain cancer	0.000519	0.00892	CbGpPWpGaD
Dapsone—Sulfaphenazole—CYP2C9—brain cancer	0.000497	0.08	CrCbGaD
Dapsone—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000494	0.0085	CbGpPWpGaD
Dapsone—CYP3A7—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000488	0.00839	CbGpPWpGaD
Dapsone—MPO—spinal cord—brain cancer	0.000484	0.0157	CbGeAlD
Dapsone—MPO—Vitamin B12 Metabolism—SOD2—brain cancer	0.000478	0.00822	CbGpPWpGaD
Dapsone—FMO3—brain—brain cancer	0.000472	0.0153	CbGeAlD
Dapsone—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000457	0.00786	CbGpPWpGaD
Dapsone—PTGS2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00044	0.00757	CbGpPWpGaD
Dapsone—MPO—C-MYB transcription factor network—CDK6—brain cancer	0.000437	0.00751	CbGpPWpGaD
Dapsone—MPO—endocrine gland—brain cancer	0.000435	0.0141	CbGeAlD
Dapsone—MPO—head—brain cancer	0.00043	0.0139	CbGeAlD
Dapsone—Sulfamethoxazole—CYP2C9—brain cancer	0.000421	0.0677	CrCbGaD
Dapsone—CYP3A7—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000401	0.00689	CbGpPWpGaD
Dapsone—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.0004	0.00688	CbGpPWpGaD
Dapsone—MPO—central nervous system—brain cancer	0.000392	0.0127	CbGeAlD
Dapsone—MPO—Folate Metabolism—SOD2—brain cancer	0.000389	0.00669	CbGpPWpGaD
Dapsone—PTGS1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000388	0.00668	CbGpPWpGaD
Dapsone—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000385	0.00662	CbGpPWpGaD
Dapsone—Sulfanilamide—CYP2C9—brain cancer	0.000369	0.0594	CrCbGaD
Dapsone—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000358	0.00616	CbGpPWpGaD
Dapsone—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000358	0.00616	CbGpPWpGaD
Dapsone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000357	0.00615	CbGpPWpGaD
Dapsone—MPO—IL23-mediated signaling events—RELA—brain cancer	0.000357	0.00614	CbGpPWpGaD
Dapsone—CYP2E1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000353	0.00608	CbGpPWpGaD
Dapsone—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000353	0.00607	CbGpPWpGaD
Dapsone—CYP2E1—telencephalon—brain cancer	0.00034	0.011	CbGeAlD
Dapsone—CYP2C8—pituitary gland—brain cancer	0.000329	0.0106	CbGeAlD
Dapsone—PTGS1—telencephalon—brain cancer	0.000327	0.0106	CbGeAlD
Dapsone—MPO—IL23-mediated signaling events—IL2—brain cancer	0.000322	0.00553	CbGpPWpGaD
Dapsone—MPO—C-MYB transcription factor network—HES1—brain cancer	0.000321	0.00553	CbGpPWpGaD
Dapsone—CYP2C18—Biological oxidations—CYP2C9—brain cancer	0.00032	0.00551	CbGpPWpGaD
Dapsone—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00032	0.0055	CbGpPWpGaD
Dapsone—CYP2C18—Metapathway biotransformation—CYP2C9—brain cancer	0.000316	0.00543	CbGpPWpGaD
Dapsone—PTGS2—telencephalon—brain cancer	0.000313	0.0101	CbGeAlD
Dapsone—MPO—brain—brain cancer	0.000311	0.0101	CbGeAlD
Dapsone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00031	0.00532	CbGpPWpGaD
Dapsone—MPO—Selenium Micronutrient Network—SOD2—brain cancer	0.000309	0.00531	CbGpPWpGaD
Dapsone—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000305	0.00525	CbGpPWpGaD
Dapsone—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.000304	0.00522	CbGpPWpGaD
Dapsone—CYP2C19—endocrine gland—brain cancer	0.000292	0.00945	CbGeAlD
Dapsone—CYP2E1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00029	0.00499	CbGpPWpGaD
Dapsone—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00029	0.00498	CbGpPWpGaD
Dapsone—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000276	0.00475	CbGpPWpGaD
Dapsone—MPO—Vitamin B12 Metabolism—RELA—brain cancer	0.000276	0.00475	CbGpPWpGaD
Dapsone—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000275	0.00472	CbGpPWpGaD
Dapsone—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000273	0.00469	CbGpPWpGaD
Dapsone—MPO—IL23-mediated signaling events—STAT3—brain cancer	0.000271	0.00465	CbGpPWpGaD
Dapsone—CYP2E1—medulla oblongata—brain cancer	0.000267	0.00864	CbGeAlD
Dapsone—PTGS1—pituitary gland—brain cancer	0.000267	0.00863	CbGeAlD
Dapsone—FMO3—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000263	0.00452	CbGpPWpGaD
Dapsone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000262	0.0045	CbGpPWpGaD
Dapsone—PTGS2—pituitary gland—brain cancer	0.000255	0.00825	CbGeAlD
Dapsone—CYP2C8—endocrine gland—brain cancer	0.000255	0.00824	CbGeAlD
Dapsone—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000251	0.00432	CbGpPWpGaD
Dapsone—PTGS2—medulla oblongata—brain cancer	0.000246	0.00796	CbGeAlD
Dapsone—CYP2E1—spinal cord—brain cancer	0.000238	0.00771	CbGeAlD
Dapsone—CYP3A5—endocrine gland—brain cancer	0.00023	0.00744	CbGeAlD
Dapsone—PTGS1—spinal cord—brain cancer	0.000229	0.00743	CbGeAlD
Dapsone—CYP2C9—endocrine gland—brain cancer	0.000226	0.00732	CbGeAlD
Dapsone—MPO—Folate Metabolism—RELA—brain cancer	0.000225	0.00387	CbGpPWpGaD
Dapsone—PTGS2—midbrain—brain cancer	0.000225	0.00728	CbGeAlD
Dapsone—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000224	0.00385	CbGpPWpGaD
Dapsone—PTGS2—spinal cord—brain cancer	0.000219	0.0071	CbGeAlD
Dapsone—CYP2E1—endocrine gland—brain cancer	0.000214	0.00694	CbGeAlD
Dapsone—CYP3A7—Biological oxidations—CYP2C9—brain cancer	0.000213	0.00366	CbGpPWpGaD
Dapsone—CYP2E1—head—brain cancer	0.000212	0.00685	CbGeAlD
Dapsone—CYP3A7—Metapathway biotransformation—CYP2C9—brain cancer	0.00021	0.00361	CbGpPWpGaD
Dapsone—PTGS1—endocrine gland—brain cancer	0.000207	0.00669	CbGeAlD
Dapsone—PTGS1—Biological oxidations—CYP2C9—brain cancer	0.000206	0.00355	CbGpPWpGaD
Dapsone—FMO3—SIDS Susceptibility Pathways—HES1—brain cancer	0.000204	0.00351	CbGpPWpGaD
Dapsone—PTGS1—head—brain cancer	0.000204	0.0066	CbGeAlD
Dapsone—MPO—Folate Metabolism—IL2—brain cancer	0.000202	0.00348	CbGpPWpGaD
Dapsone—PTGS2—endocrine gland—brain cancer	0.000197	0.00639	CbGeAlD
Dapsone—PTGS2—head—brain cancer	0.000195	0.00631	CbGeAlD
Dapsone—CYP2E1—central nervous system—brain cancer	0.000193	0.00625	CbGeAlD
Dapsone—MPO—C-MYB transcription factor network—CDKN2A—brain cancer	0.000193	0.00331	CbGpPWpGaD
Dapsone—CYP2E1—cerebellum—brain cancer	0.000189	0.00611	CbGeAlD
Dapsone—PTGS1—central nervous system—brain cancer	0.000186	0.00602	CbGeAlD
Dapsone—CYP2C8—brain—brain cancer	0.000182	0.0059	CbGeAlD
Dapsone—MPO—Selenium Micronutrient Network—RELA—brain cancer	0.000179	0.00307	CbGpPWpGaD
Dapsone—PTGS2—central nervous system—brain cancer	0.000178	0.00576	CbGeAlD
Dapsone—PTGS2—cerebellum—brain cancer	0.000174	0.00563	CbGeAlD
Dapsone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	0.000174	0.00299	CbGpPWpGaD
Dapsone—CYP3A4—endocrine gland—brain cancer	0.000172	0.00558	CbGeAlD
Dapsone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000166	0.00286	CbGpPWpGaD
Dapsone—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000164	0.00282	CbGpPWpGaD
Dapsone—MPO—C-MYB transcription factor network—CCND1—brain cancer	0.000163	0.0028	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—GFAP—brain cancer	0.000162	0.00278	CbGpPWpGaD
Dapsone—CYP3A4—central nervous system—brain cancer	0.000155	0.00503	CbGeAlD
Dapsone—CYP2E1—Biological oxidations—CYP2C9—brain cancer	0.000154	0.00265	CbGpPWpGaD
Dapsone—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.000154	0.00265	CbGpPWpGaD
Dapsone—CYP2E1—brain—brain cancer	0.000153	0.00496	CbGeAlD
Dapsone—CYP2E1—Metapathway biotransformation—CYP2C9—brain cancer	0.000152	0.00262	CbGpPWpGaD
Dapsone—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.000152	0.00261	CbGpPWpGaD
Dapsone—PTGS2—S1P1 pathway—VEGFA—brain cancer	0.000151	0.0026	CbGpPWpGaD
Dapsone—PTGS1—brain—brain cancer	0.000148	0.00478	CbGeAlD
Dapsone—PTGS2—C-MYB transcription factor network—CDK6—brain cancer	0.000142	0.00244	CbGpPWpGaD
Dapsone—PTGS2—brain—brain cancer	0.000141	0.00457	CbGeAlD
Dapsone—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000141	0.00243	CbGpPWpGaD
Dapsone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000135	0.00232	CbGpPWpGaD
Dapsone—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.000133	0.00229	CbGpPWpGaD
Dapsone—Skin exfoliation—Hydroxyurea—brain cancer	0.000133	0.0399	CcSEcCtD
Dapsone—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000131	0.00226	CbGpPWpGaD
Dapsone—MPO—C-MYB transcription factor network—MYC—brain cancer	0.000131	0.00224	CbGpPWpGaD
Dapsone—MPO—Folate Metabolism—TP53—brain cancer	0.00013	0.00224	CbGpPWpGaD
Dapsone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—brain cancer	0.000127	0.00218	CbGpPWpGaD
Dapsone—PTGS1—Selenium Micronutrient Network—SOD2—brain cancer	0.000126	0.00217	CbGpPWpGaD
Dapsone—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000125	0.00215	CbGpPWpGaD
Dapsone—NAT2—Metabolism—CYP2C9—brain cancer	0.000124	0.00214	CbGpPWpGaD
Dapsone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—brain cancer	0.000124	0.00213	CbGpPWpGaD
Dapsone—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000119	0.00205	CbGpPWpGaD
Dapsone—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000117	0.00202	CbGpPWpGaD
Dapsone—Pancreatitis—Procarbazine—brain cancer	0.00011	0.0332	CcSEcCtD
Dapsone—Skin exfoliation—Carmustine—brain cancer	0.000107	0.0322	CcSEcCtD
Dapsone—NAT2—Metabolism—BSG—brain cancer	0.000106	0.00182	CbGpPWpGaD
Dapsone—PTGS2—C-MYB transcription factor network—HES1—brain cancer	0.000104	0.0018	CbGpPWpGaD
Dapsone—Skin exfoliation—Temozolomide—brain cancer	0.000104	0.0311	CcSEcCtD
Dapsone—Photosensitivity reaction—Procarbazine—brain cancer	0.000103	0.0309	CcSEcCtD
Dapsone—FMO3—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000102	0.00176	CbGpPWpGaD
Dapsone—PTGS2—Selenium Micronutrient Network—SOD2—brain cancer	0.0001	0.00173	CbGpPWpGaD
Dapsone—Neuropathy peripheral—Procarbazine—brain cancer	9.84e-05	0.0296	CcSEcCtD
Dapsone—PTGS2—Aryl Hydrocarbon Receptor—RELA—brain cancer	9.75e-05	0.00168	CbGpPWpGaD
Dapsone—Body temperature increased—Carboplatin—brain cancer	9.12e-05	0.0274	CcSEcCtD
Dapsone—NAT2—Metabolism—IDH1—brain cancer	9.1e-05	0.00156	CbGpPWpGaD
Dapsone—FMO3—SIDS Susceptibility Pathways—VEGFA—brain cancer	9.02e-05	0.00155	CbGpPWpGaD
Dapsone—FMO3—Metabolism—CYP2C9—brain cancer	8.99e-05	0.00155	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	8.71e-05	0.0015	CbGpPWpGaD
Dapsone—Pancreatitis—Hydroxyurea—brain cancer	8.55e-05	0.0257	CcSEcCtD
Dapsone—Skin exfoliation—Etoposide—brain cancer	8.29e-05	0.0249	CcSEcCtD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	8.25e-05	0.00142	CbGpPWpGaD
Dapsone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—brain cancer	8.21e-05	0.00141	CbGpPWpGaD
Dapsone—Body temperature increased—Lomustine—brain cancer	7.98e-05	0.024	CcSEcCtD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.92e-05	0.00136	CbGpPWpGaD
Dapsone—FMO3—Metabolism—BSG—brain cancer	7.65e-05	0.00132	CbGpPWpGaD
Dapsone—Neuropathy peripheral—Hydroxyurea—brain cancer	7.62e-05	0.0229	CcSEcCtD
Dapsone—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	7.46e-05	0.00128	CbGpPWpGaD
Dapsone—PTGS1—Selenium Micronutrient Network—RELA—brain cancer	7.31e-05	0.00126	CbGpPWpGaD
Dapsone—Muscular weakness—Carmustine—brain cancer	7.19e-05	0.0216	CcSEcCtD
Dapsone—NAT2—Metabolism—ENO2—brain cancer	7.19e-05	0.00124	CbGpPWpGaD
Dapsone—CYP3A4—Biological oxidations—CYP2C9—brain cancer	7.15e-05	0.00123	CbGpPWpGaD
Dapsone—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	7.06e-05	0.00121	CbGpPWpGaD
Dapsone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—brain cancer	7.01e-05	0.00121	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	6.97e-05	0.0012	CbGpPWpGaD
Dapsone—Muscular weakness—Temozolomide—brain cancer	6.95e-05	0.0209	CcSEcCtD
Dapsone—PTGS2—Aryl Hydrocarbon Receptor—MYC—brain cancer	6.86e-05	0.00118	CbGpPWpGaD
Dapsone—Cough—Procarbazine—brain cancer	6.85e-05	0.0206	CcSEcCtD
Dapsone—PTGS2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	6.71e-05	0.00115	CbGpPWpGaD
Dapsone—FMO3—Metabolism—IDH1—brain cancer	6.58e-05	0.00113	CbGpPWpGaD
Dapsone—Vomiting—Lomustine—brain cancer	6.41e-05	0.0193	CcSEcCtD
Dapsone—PTGS2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	6.29e-05	0.00108	CbGpPWpGaD
Dapsone—PTGS2—C-MYB transcription factor network—CDKN2A—brain cancer	6.26e-05	0.00108	CbGpPWpGaD
Dapsone—Tachycardia—Procarbazine—brain cancer	6.25e-05	0.0188	CcSEcCtD
Dapsone—PTGS2—Spinal Cord Injury—CDK4—brain cancer	6.24e-05	0.00107	CbGpPWpGaD
Dapsone—Photosensitivity reaction—Temozolomide—brain cancer	6.22e-05	0.0187	CcSEcCtD
Dapsone—Neuropathy peripheral—Carmustine—brain cancer	6.16e-05	0.0185	CcSEcCtD
Dapsone—Erythema—Hydroxyurea—brain cancer	6.07e-05	0.0182	CcSEcCtD
Dapsone—Nausea—Lomustine—brain cancer	5.99e-05	0.018	CcSEcCtD
Dapsone—Neuropathy peripheral—Temozolomide—brain cancer	5.95e-05	0.0179	CcSEcCtD
Dapsone—PTGS2—Selenium Micronutrient Network—RELA—brain cancer	5.8e-05	0.000998	CbGpPWpGaD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.79e-05	0.000996	CbGpPWpGaD
Dapsone—Insomnia—Procarbazine—brain cancer	5.79e-05	0.0174	CcSEcCtD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	5.72e-05	0.000984	CbGpPWpGaD
Dapsone—Sinusitis—Temozolomide—brain cancer	5.7e-05	0.0171	CcSEcCtD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	5.61e-05	0.000965	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	5.54e-05	0.000953	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—CYP2C9—brain cancer	5.48e-05	0.000942	CbGpPWpGaD
Dapsone—Pharyngitis—Temozolomide—brain cancer	5.41e-05	0.0163	CcSEcCtD
Dapsone—PTGS2—C-MYB transcription factor network—CCND1—brain cancer	5.29e-05	0.000909	CbGpPWpGaD
Dapsone—Gastrointestinal pain—Procarbazine—brain cancer	5.24e-05	0.0157	CcSEcCtD
Dapsone—FMO3—Metabolism—ENO2—brain cancer	5.2e-05	0.000894	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	5.15e-05	0.000886	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.12e-05	0.00088	CbGpPWpGaD
Dapsone—Tinnitus—Temozolomide—brain cancer	5.08e-05	0.0153	CcSEcCtD
Dapsone—Body temperature increased—Procarbazine—brain cancer	5.06e-05	0.0152	CcSEcCtD
Dapsone—Abdominal pain—Procarbazine—brain cancer	5.06e-05	0.0152	CcSEcCtD
Dapsone—PTGS2—Disease—DTX2—brain cancer	4.95e-05	0.000852	CbGpPWpGaD
Dapsone—Erythema—Carmustine—brain cancer	4.91e-05	0.0148	CcSEcCtD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	4.91e-05	0.000844	CbGpPWpGaD
Dapsone—Neuropathy peripheral—Etoposide—brain cancer	4.76e-05	0.0143	CcSEcCtD
Dapsone—Erythema—Temozolomide—brain cancer	4.75e-05	0.0143	CcSEcCtD
Dapsone—CYP2C18—Metabolism—BSG—brain cancer	4.66e-05	0.000801	CbGpPWpGaD
Dapsone—Vision blurred—Carmustine—brain cancer	4.63e-05	0.0139	CcSEcCtD
Dapsone—PTGS2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.6e-05	0.000791	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.57e-05	0.000786	CbGpPWpGaD
Dapsone—Vision blurred—Temozolomide—brain cancer	4.47e-05	0.0134	CcSEcCtD
Dapsone—Vertigo—Temozolomide—brain cancer	4.26e-05	0.0128	CcSEcCtD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	4.24e-05	0.00073	CbGpPWpGaD
Dapsone—PTGS2—C-MYB transcription factor network—MYC—brain cancer	4.24e-05	0.000729	CbGpPWpGaD
Dapsone—Cough—Temozolomide—brain cancer	4.14e-05	0.0124	CcSEcCtD
Dapsone—PTGS2—Spinal Cord Injury—IL2—brain cancer	4.13e-05	0.000711	CbGpPWpGaD
Dapsone—Vomiting—Procarbazine—brain cancer	4.07e-05	0.0122	CcSEcCtD
Dapsone—PTGS2—Spinal Cord Injury—CCND1—brain cancer	4.03e-05	0.000693	CbGpPWpGaD
Dapsone—Headache—Procarbazine—brain cancer	4.01e-05	0.0121	CcSEcCtD
Dapsone—CYP2C18—Metabolism—IDH1—brain cancer	4e-05	0.000689	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—APC—brain cancer	3.99e-05	0.000687	CbGpPWpGaD
Dapsone—Body temperature increased—Hydroxyurea—brain cancer	3.92e-05	0.0118	CcSEcCtD
Dapsone—Tachycardia—Carmustine—brain cancer	3.91e-05	0.0118	CcSEcCtD
Dapsone—Nausea—Procarbazine—brain cancer	3.8e-05	0.0114	CcSEcCtD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.74e-05	0.000644	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—CYP2C9—brain cancer	3.64e-05	0.000626	CbGpPWpGaD
Dapsone—PTGS2—Disease—HES5—brain cancer	3.63e-05	0.000625	CbGpPWpGaD
Dapsone—Insomnia—Carmustine—brain cancer	3.62e-05	0.0109	CcSEcCtD
Dapsone—PTGS1—Metabolism—CYP2C9—brain cancer	3.53e-05	0.000607	CbGpPWpGaD
Dapsone—Insomnia—Temozolomide—brain cancer	3.5e-05	0.0105	CcSEcCtD
Dapsone—Vertigo—Etoposide—brain cancer	3.41e-05	0.0102	CcSEcCtD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.34e-05	0.000575	CbGpPWpGaD
Dapsone—Cough—Etoposide—brain cancer	3.31e-05	0.00995	CcSEcCtD
Dapsone—NAT2—Metabolism—PIK3CG—brain cancer	3.3e-05	0.000567	CbGpPWpGaD
Dapsone—Gastrointestinal pain—Carmustine—brain cancer	3.28e-05	0.00984	CcSEcCtD
Dapsone—PTGS2—Spinal Cord Injury—MYC—brain cancer	3.23e-05	0.000556	CbGpPWpGaD
Dapsone—Body temperature increased—Carmustine—brain cancer	3.17e-05	0.00952	CcSEcCtD
Dapsone—Abdominal pain—Carmustine—brain cancer	3.17e-05	0.00952	CcSEcCtD
Dapsone—Gastrointestinal pain—Temozolomide—brain cancer	3.17e-05	0.00951	CcSEcCtD
Dapsone—CYP2C18—Metabolism—ENO2—brain cancer	3.17e-05	0.000544	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—EGFR—brain cancer	3.16e-05	0.000543	CbGpPWpGaD
Dapsone—Vomiting—Hydroxyurea—brain cancer	3.15e-05	0.00947	CcSEcCtD
Dapsone—Headache—Hydroxyurea—brain cancer	3.11e-05	0.00933	CcSEcCtD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	3.1e-05	0.000533	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—BSG—brain cancer	3.1e-05	0.000532	CbGpPWpGaD
Dapsone—Abdominal pain—Temozolomide—brain cancer	3.06e-05	0.0092	CcSEcCtD
Dapsone—Body temperature increased—Temozolomide—brain cancer	3.06e-05	0.0092	CcSEcCtD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.05e-05	0.000524	CbGpPWpGaD
Dapsone—Tachycardia—Etoposide—brain cancer	3.02e-05	0.00909	CcSEcCtD
Dapsone—PTGS1—Metabolism—BSG—brain cancer	3e-05	0.000516	CbGpPWpGaD
Dapsone—Nausea—Hydroxyurea—brain cancer	2.94e-05	0.00885	CcSEcCtD
Dapsone—PTGS2—Metabolism—CYP2C9—brain cancer	2.8e-05	0.000482	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	2.74e-05	0.000471	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	2.71e-05	0.000467	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—IDH1—brain cancer	2.66e-05	0.000458	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—TP53—brain cancer	2.65e-05	0.000456	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—CYP2C9—brain cancer	2.64e-05	0.000454	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—CYP2C9—brain cancer	2.63e-05	0.000453	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—IDH1—brain cancer	2.58e-05	0.000444	CbGpPWpGaD
Dapsone—Vomiting—Carmustine—brain cancer	2.55e-05	0.00765	CcSEcCtD
Dapsone—Gastrointestinal pain—Etoposide—brain cancer	2.53e-05	0.00761	CcSEcCtD
Dapsone—Headache—Carmustine—brain cancer	2.51e-05	0.00754	CcSEcCtD
Dapsone—Vomiting—Temozolomide—brain cancer	2.46e-05	0.0074	CcSEcCtD
Dapsone—Abdominal pain—Etoposide—brain cancer	2.45e-05	0.00736	CcSEcCtD
Dapsone—Body temperature increased—Etoposide—brain cancer	2.45e-05	0.00736	CcSEcCtD
Dapsone—PTGS2—Disease—IDH1—brain cancer	2.45e-05	0.000421	CbGpPWpGaD
Dapsone—Headache—Temozolomide—brain cancer	2.43e-05	0.00729	CcSEcCtD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	2.39e-05	0.000411	CbGpPWpGaD
Dapsone—FMO3—Metabolism—PIK3CG—brain cancer	2.38e-05	0.00041	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—BSG—brain cancer	2.38e-05	0.00041	CbGpPWpGaD
Dapsone—Nausea—Carmustine—brain cancer	2.38e-05	0.00715	CcSEcCtD
Dapsone—PTGS2—Disease—HEY1—brain cancer	2.32e-05	0.000399	CbGpPWpGaD
Dapsone—Nausea—Temozolomide—brain cancer	2.3e-05	0.00691	CcSEcCtD
Dapsone—CYP2C8—Metabolism—CYP2C9—brain cancer	2.28e-05	0.000392	CbGpPWpGaD
Dapsone—PTGS2—Disease—DLL1—brain cancer	2.27e-05	0.000391	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—BSG—brain cancer	2.24e-05	0.000386	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—BSG—brain cancer	2.24e-05	0.000385	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	2.2e-05	0.000378	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	2.15e-05	0.00037	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—ENO2—brain cancer	2.1e-05	0.000362	CbGpPWpGaD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.1e-05	0.000361	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—IDH1—brain cancer	2.05e-05	0.000352	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—ENO2—brain cancer	2.04e-05	0.000351	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—CYP2C9—brain cancer	2.03e-05	0.00035	CbGpPWpGaD
Dapsone—Vomiting—Etoposide—brain cancer	1.97e-05	0.00592	CcSEcCtD
Dapsone—Headache—Etoposide—brain cancer	1.94e-05	0.00583	CcSEcCtD
Dapsone—CYP2C8—Metabolism—BSG—brain cancer	1.94e-05	0.000333	CbGpPWpGaD
Dapsone—PTGS2—Disease—SHH—brain cancer	1.93e-05	0.000333	CbGpPWpGaD
Dapsone—PTGS2—Disease—ENO2—brain cancer	1.93e-05	0.000333	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—IDH1—brain cancer	1.93e-05	0.000332	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—IDH1—brain cancer	1.92e-05	0.000331	CbGpPWpGaD
Dapsone—Nausea—Etoposide—brain cancer	1.84e-05	0.00553	CcSEcCtD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.8e-05	0.00031	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—BSG—brain cancer	1.73e-05	0.000298	CbGpPWpGaD
Dapsone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.67e-05	0.000287	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—IDH1—brain cancer	1.67e-05	0.000287	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—ENO2—brain cancer	1.62e-05	0.000278	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—BSG—brain cancer	1.58e-05	0.000271	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—ENO2—brain cancer	1.52e-05	0.000262	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—ENO2—brain cancer	1.52e-05	0.000262	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—IDH1—brain cancer	1.49e-05	0.000256	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—PIK3CG—brain cancer	1.45e-05	0.00025	CbGpPWpGaD
Dapsone—PTGS2—Disease—VAV1—brain cancer	1.4e-05	0.00024	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.36e-05	0.000233	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—IDH1—brain cancer	1.36e-05	0.000233	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—ENO2—brain cancer	1.32e-05	0.000227	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—CYP2C9—brain cancer	1.22e-05	0.00021	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.21e-05	0.000208	CbGpPWpGaD
Dapsone—PTGS2—Disease—HES1—brain cancer	1.2e-05	0.000207	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—ENO2—brain cancer	1.18e-05	0.000202	CbGpPWpGaD
Dapsone—PTGS2—Disease—PDGFRA—brain cancer	1.14e-05	0.000197	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.1e-05	0.00019	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—ENO2—brain cancer	1.07e-05	0.000184	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—BSG—brain cancer	1.04e-05	0.000179	CbGpPWpGaD
Dapsone—PTGS2—Disease—IRS2—brain cancer	1e-05	0.000173	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—PIK3CG—brain cancer	9.65e-06	0.000166	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—PIK3CG—brain cancer	9.36e-06	0.000161	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—IDH1—brain cancer	8.95e-06	0.000154	CbGpPWpGaD
Dapsone—PTGS2—Disease—APC—brain cancer	8.87e-06	0.000153	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—PIK3CG—brain cancer	7.43e-06	0.000128	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—ENO2—brain cancer	7.07e-06	0.000122	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—PIK3CG—brain cancer	6.99e-06	0.00012	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—PIK3CG—brain cancer	6.98e-06	0.00012	CbGpPWpGaD
Dapsone—PTGS2—Disease—ERBB2—brain cancer	6.89e-06	0.000118	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—PIK3CG—brain cancer	6.04e-06	0.000104	CbGpPWpGaD
Dapsone—PTGS2—Disease—CTNNB1—brain cancer	6.03e-06	0.000104	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—PIK3CG—brain cancer	5.39e-06	9.28e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—STAT3—brain cancer	5.25e-06	9.03e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—PIK3CG—brain cancer	4.92e-06	8.46e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—MYC—brain cancer	4.88e-06	8.39e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—EGFR—brain cancer	4.77e-06	8.21e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—PIK3CG—brain cancer	3.24e-06	5.58e-05	CbGpPWpGaD
